Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
13.05
-0.44 (-3.26%)
Dec 3, 2024, 2:03 PM EST - Market open
Mineralys Therapeutics Employees
Mineralys Therapeutics had 28 employees as of December 31, 2023. The number of employees increased by 16 or 133.33% compared to the previous year.
Employees
28
Change (1Y)
16
Growth (1Y)
133.33%
Revenue / Employee
n/a
Profits / Employee
-$5,473,321
Market Cap
649.48M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 28 | 16 | 133.33% |
Dec 31, 2022 | 12 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Varex Imaging | 2,400 |
InnovAge Holding | 2,350 |
CureVac | 1,172 |
Butterfly Network | 225 |
IGM Biosciences | 224 |
Omeros | 198 |
IRADIMED CORPORATION | 148 |
ORIC Pharmaceuticals | 100 |
MLYS News
- 21 days ago - Mineralys Therapeutics, Inc. (MLYS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 27 days ago - Mineralys Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Mineralys Therapeutics to Announce Third Quarter 2024 Financial Results and Host Conference Call on Monday, November 11, 2024 - GlobeNewsWire
- 5 weeks ago - Mineralys Therapeutics Inc Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 5 weeks ago - The Schall Law Firm Invites Investors To Join An Inquiry Into Mineralys Therapeutics, Inc. For Securities Fraud - Accesswire
- 5 weeks ago - Mineralys Therapeutics Inc Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
- 6 weeks ago - The Schall Law Firm Encourages Investor Participation In An Inquiry Into Mineralys Therapeutics, Inc. For Securities Fraud - Accesswire